Listening
Episodes
One search box across the whole catalog, titles and show notes alike. It earns its keep when you half-remember a case, a device or a name and want the conversation it came up in.
5,508 episodes · 33 shows
Audio unavailablePfizer + Biohaven, Regulators, Lilly, BridgeBio + BMS
An $11.6B yes, $11.7B delay, drop the AIC with GLP, and a billion bio-bucksFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesPfizer + BiohavenRegulatorsLillyBridgeBio + BMSAbout the ShowLife Science Today is your source for…
- Audio unavailable
Zymeworks, Phathom, Catalyst, CenExel, Intercept + Advanz
Resets for biotech, antibiotics approval not enough, continued consolidation, and a normal dealFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesZymeworksPhathomCatalystCenExelIntercept + AdvanzAbout the ShowLife Science To…
- Audio unavailable
Merck, Sanofi, J&J, ThermoFisher, Novo Nordisk, Eli Lilly
Pharma Q1 reports are rolling in, COVID boost turned sustainable, and weight loss battle loomsFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesMerckSanofiJ&JThermoFisherNovo NordiskEli LillyAbout the ShowLife Science T…
- Audio unavailable
Orasis, Reify, Blackrock + MindX
Drops for reading, a $220M raise, and an acquisition straight out of the moviesFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesOrasisReifyBlackrock + MindXAbout the ShowLife Science Today is your source for stories, insig…
- Audio unavailable
FDA, Antares + Halozyme, GSK + Sierra, Ansa
The FDA asks for more diversity, $1B for injectors, $2B for a one-trick pony, and $68M to make DNA. Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesFDAAntares + HalozymeGSK + SierraAnsa BiotechnologiesAbout the ShowLife S…
- Audio unavailable
Pfizer + ReViral, Novartis, Charles River + Explora Labs
Viral therapies, rare disease approvals, and lab space premiumsFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesPfizer + ReViralNovartisCharles River + Explora LabsAbout the ShowLife Science Today is your source for storie…
- Audio unavailable
Ginkgo, Eagle + Acacia, Gilead, Taysha/Orchard/Silverback
Big compensation, mild mergers, a Kite in an updraft, and tightening the biotech beltFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesGinkgoEagle + AcaciaGileadTaysha/Orchard/SilverbackAbout the ShowLife Science Today is y…
- Audio unavailable
2seventy Bio, Ascendis, Apellis, Argenx
$2 billion in capital raises mostly by companies that start with the letter A. Find out more athttps://LifeScienceTodayPodcast.comStory References2seventy BioAscendisApellisArgenxAbout the ShowLife Science Today is your source for stories, …
- Audio unavailable
Alexion + Chugai, Biogen, Viatris, AbbVie
Case closed on patents, Alzheimer’s data, generic approvals, and expanded approvals. Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesAlexion + ChugaiBiogenViatrisAbbVieAbout the ShowLife Science Today is your source for s…
- Audio unavailable
Tech-clusion, Gilead, AstraZeneca + Merck + Myriad, DNAnexus
Technology for inclusion, layoffs, oncology approvals, and $200M for a tech platform. Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesGileadAstraZeneca + Merck + MyriadDNAnexus About the ShowLife Science Today is your sou…
- Audio unavailable
CRISPR Pt 2, Sanofi + Adagene, AbbVie + Syndesi, Atlas
Who owns CRISPR, a collaboration, the classics, and more money for biotech.Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesSanofi + AdageneAbbVie + SyndesiAtlasAbout the ShowLife Science Today is your source for stories, …
- Audio unavailable
Intellia + Regeneron, Purdue, Amicus
CRISPR works, the opioid epidemic makes amends (sort of), and the SPAC that wasn’tFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesIntelliaPurdue PharmaAmicus SPACAbout the ShowLife Science Today is your source for stories…
- Audio unavailable
Eli Lilly + Innovent Biologics, Agios, TC Biopharm, Blue Water Vaccines, Meihua
The PD1 that lost, biopharma earns FDA approval, and the Biotech market is cool not dead Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesEli Lilly + Innovent BiologicsAgiosTC BiopharmBlue Water VaccinesMeihua About the Sh…
- Audio unavailable
Arcellx, Intellia + Rewrite, Navitor + Janssen, ViiV
Dragons over unicorns, to CRISPR and beyond, spin-out-and-sell, and expanded approvals. Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesArcellxIntellia + RewriteNavitor + JanssenViiV About the ShowLife Science Today is yo…
- Audio unavailable
Genentech, Immunocore, Biogen, Eli Lilly, TenSixteen
Bispecific antibodies, ocular oncology, Biogen sells, Lilly Builds, and the treatment of a lifetimeFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesGenentechImmunocoreBiogenEli LillyTenSixteenAbout the ShowLife Science Tod…
- Audio unavailable
Eleusis, AbbVie/Pfizer/Leo, UCB + Zogenix, Kura, GSK - Unilever
Psychedelic SPACs, eczema frenzy, bio-outs without the biobucks, back on track, and the mega-deal that wasn’t Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesEleusisAbbvie/Pfizer/LeoUCB + ZogenixKuraGSK - UnileverAbout th…
- Audio unavailable
Scorpion & AstraZeneca, ABL & Sanofi, Vertex, Cochlear, Vaxcyte
Oncology partners, Parkinson’s partners, expanded European Commission, expanded FDA, and bacterial vaccinesFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesScorpion & AstraZeneca ABL & SanofiVertexCochlearVaxcyteAb…
- Audio unavailable
Stryker + Vocera, Merck KGaA + Exelead, BeiGene, Eikon
Devices with tech enablement, nano particles, Chinese approvals, and a massive series B for biotechnologyFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesStryker + VoceraMerck KGaA + ExeleadBeiGeneEikonAbout the ShowLife S…
- Audio unavailable
Announcements, Novartis + Gyroscope, Leo, Biogen
We’ve got a new name, gene therapy buyout, a lion of an approval, and an in-escapable spotlight. Find out more athttps://LifeScienceTodayPodcast.comStory ReferencesNovartis + GyroscopeLeoBiogenBiogen 2About the ShowLife Science Today is you…
- Audio unavailable
The Niche Episode 081 – CSL + Vifor, Oracle + Cerner, Calliditas, Omega Funds
Acquiring the acquired, EHR acquisition, first approvals, and a new fund for the new yearFind out more athttps://thenichepod.comStory ReferencesCSL + ViforOracle + CernerCalliditasOmegaAbout the ShowThe Niche Podcast brings you interviews w…
- Audio unavailable
The Niche Episode 080 – Microsoft + Nuance, Roche + Recursion, Heron, 1E, Alvotech
Antitrust AI, development AI, expanded approval, mega seeds, and biosimilar SPACsFind out more athttps://thenichepod.comStory ReferencesMicrosoft + NuanceRoche + RecursionHeron1EAlvotech Music by Luke GoodsonAbout the ShowThe Niche Podcast …
- Audio unavailable
The Niche Episode 079 – Vifor + Sanifit + Inositec, Kura, Takeda, Aadi, BioCryst, USDA
Double acquisitions in Switzerland, FDA holds and what that means, CMV therapy, rare + oncology continues, BioCryst draws millions, and deer. Find out more athttps://thenichepod.comStory ReferencesVifor + Sanifit + InositecKuraDifferential …
- Audio unavailable
The Niche Episode 078 – Benchling, Labcorp, Novo Nordisk, BioMarin, AppliedVR
Top dollar lab notes, lab consolidation, RNA sells, and two new approval areas Find out more athttps://thenichepod.comStory ReferencesBenchlingLabcorpNovo NordiskBioMarinBioMarin 2AppliedVRAppliedVR 2Music by Luke Goodsonhttps://www.soundcl…
- Audio unavailable
The Niche Episode 077 – Johnson & Johnson, Organon, Medicare, PharmaEssentia, Arbor Biotechnologies, Glen de Vries
A giant breaks in two, acquisitions in women’s health, Medicare cost, rare approvals, more CRISPR, and a legacyFind out more athttps://thenichepod.comStory ReferencesJohnson & JohnsonOrganonMedicarePharmaEssentiaArbor BiotechnologiesGle…